These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 7698199

  • 1. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P, Chagraoui A, Arbaoui J, Mocaër E.
    Eur J Pharmacol; 1994 Dec 12; 271(1):167-77. PubMed ID: 7698199
    [Abstract] [Full Text] [Related]

  • 2. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 3. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM, Wallsten CE, Jerning E, Hu PS, Deveney AM.
    Psychopharmacology (Berl); 1998 Oct 10; 139(4):300-10. PubMed ID: 9809851
    [Abstract] [Full Text] [Related]

  • 4. Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist.
    Matuszewich L, Lorrain DS, Trujillo R, Dominguez J, Putnam SK, Hull EM.
    Brain Res; 1999 Feb 27; 820(1-2):55-62. PubMed ID: 10023030
    [Abstract] [Full Text] [Related]

  • 5. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.
    Hajós-Korcsok E, Sharp T.
    Eur J Pharmacol; 1996 Oct 31; 314(3):285-91. PubMed ID: 8957248
    [Abstract] [Full Text] [Related]

  • 6. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec 31; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 7. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N, Kitamura M, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):235-41. PubMed ID: 8858293
    [Abstract] [Full Text] [Related]

  • 8. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 9. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
    Salmi P, Karlsson T, Ahlenius S.
    Eur J Pharmacol; 1994 Feb 21; 253(1-2):67-73. PubMed ID: 7912199
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H, Gerlach J, Peacock L.
    Psychopharmacology (Berl); 1993 Feb 21; 112(2-3):389-97. PubMed ID: 7871047
    [Abstract] [Full Text] [Related]

  • 11. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE.
    Psychopharmacology (Berl); 1986 Feb 21; 90(3):287-94. PubMed ID: 2947255
    [Abstract] [Full Text] [Related]

  • 12. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.
    Wadenberg ML.
    J Neural Transm Gen Sect; 1992 Feb 21; 89(1-2):49-59. PubMed ID: 1418867
    [Abstract] [Full Text] [Related]

  • 13. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 21; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 14. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
    Swerdlow NR, Keith VA, Braff DL, Geyer MA.
    J Pharmacol Exp Ther; 1991 Feb 21; 256(2):530-6. PubMed ID: 1825226
    [Abstract] [Full Text] [Related]

  • 15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T.
    Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561
    [Abstract] [Full Text] [Related]

  • 16. Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine.
    Wadenberg ML, Ahlenius S, Svensson TH.
    Psychopharmacology (Berl); 1993 May 15; 110(3):273-9. PubMed ID: 7831419
    [Abstract] [Full Text] [Related]

  • 17. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
    Wadenberg ML, Ahlenius S.
    J Neural Transm Gen Sect; 1991 May 15; 83(1-2):43-53. PubMed ID: 1673344
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M, von Euler G.
    Neurochem Int; 2001 Jan 15; 38(1):31-42. PubMed ID: 10913686
    [Abstract] [Full Text] [Related]

  • 19. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A, Kwek P, Chavez C, van den Buuse M.
    J Pharmacol Exp Ther; 2010 Apr 15; 333(1):218-27. PubMed ID: 20042529
    [Abstract] [Full Text] [Related]

  • 20. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA, Himmler C, Bonta T, Rice LL.
    Psychopharmacology (Berl); 1998 Dec 15; 140(4):387-97. PubMed ID: 9888612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.